Clinical Trials in Cardiology - P

Maintained by Dr. Olga Shindler. Last update on February 20, 2001.

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /

P2C2
Pediatric Pulmonary and Cardiovascular Complications of HIV infection study
P2C2HIV Web Page.

(a) Pediatric Cardiology 2000;21(3):189-196
(b) Pediatrics 1999;104:2,e14
(c) Pediatrics 1999 Jul;104(1):e6
(d) Circulation 1998 Apr 7;97(13):1246-56
(e) Circulation 1998;97:1246-1256
(f) J Am Coll Cardiol 1998 Nov 15;32(6):1749-55
(g) J Acquir Immune Defic Syndr Hum Retrovirol 1998 Dec.15;19(5):462-70
(h) J Clin Epidemiol 1996 Nov;49(11):1285-94
(j) Ann N Y Acad Sci 1993 Oct 29;693:35-51

PACE
Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly
(a) J Am Geriatr Soc 1991;39:484-491
(b) Clin Pharmacol Ther 1993;54:84-89
(c) J Am Geriatr Soc 1994;42:643-647

PACIFIC randomized trial
Potential Angina Class Improvement From Intramyocardial Channels
Lancet 2000 Nov 18;356(9243):1705-10

PACK
Prevention of Atherosclerotic Complications with Ketanserin
(a) BMJ 1980;298:424-30
(b) BMJ 1989;298:424-430
(c) Vasc Med 1996;1:135-140

PACT
Philadelphia Association of Clinical Trials study
Am J Cardiol 1989;63:37B-41B

PACT
Plasminogen Activator Angioplasty Compatibility Trial
(a) J Am Coll Cardiol. 1999 Dec;34(7):1954-62
(b) Intern Med News, Feb 15, 1998 Vol 4,page1

PACT
Plasminogen Activator Coronary-angioplasty Trial

PACT
Pre-hospital Application of Coronary Thrombolysis

PACT
Prescription Analyses and CosT
Br J Gen Pract 1996 Jan;46(402):20-5
Br J Gen Pract 1996 Feb;46(403):63-7
Rev Sanid Hig Publica (Madr) 1994 May-Jun;68(3):355-9

PACT
Pro-urokinase in Acute Coronary Thrombosis

PACTE
Prevention des ACcidents Thrombo-Emboliques chez les porteurs de prostheses vaivulaires cardiaques

PAFIT
Paroxysmal Atrial Fibrillation Italian Trial

PAIMS
Plasminogen Activator Italian Multicenter Study
J Am Coll Cardiol 1989;13:19-26

PAIMS 2
Plasminogen Activator Italian Multicenter Study 2
J Am Coll Cardiol 1992;20:520-526

PAIVS
Pulmonary Atresia with Intact Ventricular Septum collaborative study

PAMELA
studio della Pressioni- AMbulatoriali E Loro Associazioni
J Cardiovasc Pharmacol 1994;23(suppl 5):S12-S25

PAMI (pooled analysis of the primary angioplasty in myocardial infarction trials)
Primary Angioplasty in Myocardial Infarction
Am J Cardiol 2000 Jul 1;86(1):30-4

PAMI I
Primary Angioplasty in Myocardial Infarction
(a) J Am Coll Cardiol 1999;33:640-646
(b) JACC 1997;29:901-7
(c) J Am Coll Cardiol 1995;25:370-377
(d) N Engl J Med 1993;328:673-679

PAMI I (Substudy)
Primary Angioplasty in Myocardial Infarction
(a) J Am Coll Cardiol 1999;33:640-646

PAMI II
Second Primary Angioplasty in Myocardial Infarction Trial
(a) J Am Coll Cardiol 2000 Mar 1;35(3):605-11
(b) JACC 1997;29:1459-67
(c) J Am Coll Cardiol 1997;29:1459-1467
(d) J Am Coll Cardiol 1995;25:(suppl A):430A

PAMI Stent Pilot Trial
(a) Circulation 1999 Mar 30;99(12):1548-54
(b) J Am Coll Cardiol 1998;31:23-30
(c) Clin Cardiol 1998 Feb;21(2):130
(d) J Am Coll Cardiol 1998 Jan;31(1):23-30
(e) J Invasive Cardiol 1997;9 Suppl B:24B-30B

PAR
Primary Angioplasty Research

PARADIGM
Platelet Aggregation Receptor Antagonist Dose Investigation for reperfusion Gain in Myocardial infarction
(a) J Am Coll Cardiol 1998 Dec;32(7):2003-10
(b) J Thromb Thrombolysis 1995;2(3):165-169

PARADISE
Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary events Dose Investigation and Safety Evaluation study

PARAGON
Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network
(a) Circulation 1998 Jun 23;97(24):2386-95
(b) J Am Coll Cardiol 1997;29:410A
(c) J Am Coll Cardiol 1997;29(suppl A):409A

PARAGON B
Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network
Am Heart J 2000 Apr;139(4):563-6

PARIS I
Persantine Aspirin Reinfarction Study I
Circulation 1980;62:449-461

PARIS II
Persantine Aspirin Reinfarction Study II
J Am Coll Cardiol 1986;7:251-269

PARK
Post Angioplasty Restenosis Ketansarin
(a) Circulation 1993;88:1588-1601
(b) J Invasive Cardiol 1994 Jun;6(5):160-71

PARK
Prevention of Angioplasty Reocclusion with Ketanserin
Circulation 1993;89:1588-1601

PART
Probucol Angioplasty Restenosis Trial
JACC 1997;30:855-62

PART
Prevention of Atherosclerosis with Ramipril Therapy

PARTNER
Peripheral Arterial disease Response to Taprostene with New Established Response criteria

PAS
Polish Amiodarone Study
J Am Coll Cardiol 1992;20:1056-1062

PASE
PAcemaker Selection in the Elderly, a quality-of-life study
J Interv Card Electrophysiol 1998 Jun;2(2):175-9

PASE
Physical Activity Scale for the Elderly evaluation
J Sports Med Phys Fitness 1999 Dec;39(4):336-40

PASS
Piracetam in Acute Stroke Study

PASS
Practical Applicability of Saruplase Study
Circulation 1993;88:1-22

PASS
Prehospital Applicability of Saruplase Study

PATAF
Prevention of Arterial Thromboembolism in nonvalvular Atrial Fibrillation study

PATAF
Primary Prevention of Arterial Thromboemboembolism in patients with Atrial Fibrillation
Stroke 1994;25:1318

PATCH
Planned Approach To Community Health

PATENT
Pro-urokinase And t-PA Enhancement of Thrombolysis trial
J Am Coll Cardiol 1995;26:374-379

PATHS
Prevention And Treatment of Hypertension Study

PATS
Post-stroke Antihypertensive Treatment Study
Chin Med J 1995;108:710-717

PATS
Prehospital Administration of t-PA Study
R I Med J 1991;74:405-408

PAUSE
Popliteal Artery Ultrasound Examination study

PCAD
Progression of Coronary Artery Disease study

PCAT
Parent Child Autotutorial Program

PCD
Pacemaker Cardioverter Defibrillator multicenter study

PCSS
Perth Community Stroke Study

PCVMETRA
Prevention CardioVasculaire en MEdicine du TRAvail

PDA Coil Registry
Patent Ductus Arteriousus Coil occlusion Registry

PDAY
Pathobiological Determinants of Atherosclerosis in Youth

PDAY/RFEHA
Pathobiological Determinants of Atherosclerosis in Youth/Risk Factors in Early Human Atherogenesis

PEACE
Prevention of Events with ACE inhibition study

PEACH
Physiologic Evaluation After Coronary Hyperemia

PECTE
Pulmonary Embolism Colfarit Trial in Elderly

PEER
Peer review Effectiveness Evaluation Research

PEGASUS
Percutaneous Endarterectomy, the Goal for Atherectomy Successfully guided by ultrasound

PELCA
Percutaneous Excimer Laser Coronary Angioplasty registry

PENTALYSE Study
Pentasaccharide, as an Adjunct to fibrinolysis in ST-Elevation Acute Myocardial Infarction

PEPI
Postmenopausal Estrogen/Progestin Intervention
(a) J Womens Health Gend Based Med 2000 Jul-Aug;9(6):633-43
(b) JAMA 1995 Jan 18;273(3):199-208

PERFEXT
PERFusion, PERFormance, EXercise Trial

PERM
Prospective Evaluation of Reperfusion Markers study

PET
Positron Emission Tomographic study in humans with heart failure

PHASE
Pre-Hospital Arrest Survival Evaluation study

PHICOG
PHIladelphia COoperative Group trial
Clin Ther 1989;11:94-119

PHHP
Pawtucket Heart Health Program

PHS
Physicians' Health Study (Post trial aspirin substudy)
(a) Arch Intern Med 2000 Apr 10;160(7):921-8
(b) Am Heart J 1991;122:1588-1592

Physicians' Health Study (Beta carotene )
N Engl J Med 1996;334:1145-1149
Am Heart J 1991;122:1588-1592

PHYLLIS
Plaque HYpertension Lipid Lowering Italian Study
J Hpertens 1993;11(suppl 5):S314-S315

PIAF
Pharmacological Intervention in Atrial Fibrillation study

PIC
Pacing In Cardiomyopathy study

PICO
Pimobendan In COngestive heart failure
Heart 1996 Sep;76(3):223-31

PICS
Pacing In Cardiomyopathy Study

PICSS
Patent foramen ovale In Cryptognic Stroke Study

PICTURE
Post IntraCoronary Treatment Ultrasound Result Evaluation study

PILOT
Preliminary Investigation of Local Therapy using porous PTCA balloons and low molecular weight heparin

PILP
Post-Infarction Late Potential study

PILS
PIlsen Longitudinal Study

PIMI
Psychophysiological Interventions in Myocardial Ischemia

PIOPED
Prospective Investigation Of Pulmonary Embolism Diagnosis

PLAC
Pravastatin Limitation of Atherosclerosis in the Coronary arteries

(a) Med Klin 1997 Jun 15;92(6):363-9
(b) J Am Coll Cardiol 1995 Nov 1;26(5):1133-9
(c) J Am Coll Cardiol 1995;26:1133-1139
(d) Am J Cardiol 1993 Jul 1;72(1):31-5

PLAC-2
second study of Pravastatin, Lipids, and Atherosclerosis in the Carotids

(a) Med Klin 1997 Jun 15;92(6):363-9
(b) Am J Cardiol 1995 Mar 1;75(7):455-9
(c) Am J Cardiol 1995;76:54C-59C
(d) Am J Cardiol 1995;76:60C-63C
(e) Control Clin Trials 1992 Dec;13(6):495-506

PLAT
Progetto Lombardo Atero-Trombosi study

PLM
Prevention of mortality with Low molecular weight heparin in Medical patients

PLOSA
Physiologic LOw Stress Angioplasty trial

PLS
Postsurgery Logiparin Study

PLUR
Praxisblutdruckmessung Vs Langzeitblutdruckmessung Unter der therapie mit Ramipril
Nieren-Hochdruckkr 1995;24:118-120

PMNSG
Pravastatin MultiNational Study Group trial

PMRG
Pimobendan Multicenter Research Group study

PMS
Pravastatin Multinational Study

POLONIA
POlish-American Local Lovenox NIr stent Assessment study

Pol-MONICA
MONitoring trends and determinants in CArdiovascular disease
The WHO MONICA Project is a multicentre collaborative study coordinated by The World Health Organization. The aim is to measure trends in cardiovascular disease mortality and morbidity and to assess the extent, to which these trends are related to changes in risk factor levels and in medical care measured at the same time in defined communities in different countries. There are 38 participating research centres from 21 countries from 4 continents, including two Polish centres: POL-MONICA Warszawa and POL-MONICA Krakow. Population studied in POL-MONICA Warszawa Project consisted of residents of two districts of Warsaw capital. The interest of the research of the POL-MONICA Krakow focuses on problems of the myocardial infarction in semi-rural population and the population observed consisted of men and women at age 25-64 years residents of one Polish province-Tarnobrzeg Voivodship.
Ann Epidemiol. 1998 Jan;8(1):3-13
Int J Epidemiol 1989;18(3 Suppl 1):S129-36

PORTS
Patient Outcomes Research Teams Study

POSCH
Program On Surgical Control of Hyperlipidemia
(a) Atherosclerosis 2001 Jan;154(1):221-7
(b) Atherosclerosis 1998 Jun;138(2):391-401
(c) Arch Intern Med 1998 Jun 8;158(11):1253-61
(d) Ann Surg 1996;224:486-500
(e) N engl J Med 1990;323:946-955

POSSUM
Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity

POST CABG
POST Coronary Artery Bypass Graft clinical trial

N Engl J Med 1997;336:153-162

PPH
Primary Prevention of Hypertension

PPP
Prospective Pravastatin Pooling project

PQRST
Probucol Quantitative Regression Swedish Trial
(a) Am J Cardiol 1988;62:37B-43B
(b) Am J Cardiol 1993;71:15B-19B
(c) Am J Cardiol 1994;74:875-883
(d) Arterioscler Thromb Vasc Biol 1995;15:1049-1056

PRACTICAL
Placebo-controlled Randomized Angiotensin-converting enzyme inhibition Comparative Trial In Cardiac infarction And Left ventricular function
Am J Cardiol 1994;73:1180-1186

PRAGUE
Primary Angiography in patients transferred from General community hospitals to specialized PTCA Units with or without Emergency thrombolysis
Eur Heart J 2000;21:823-831

PRAIRE
study of survival after thrombolysis for acute myocardial infarction by PRAIRE cardiovascularcenter, Springfield, Illinois

PRAISE
Prospective Randomized AmlodIpine Survival Evaluation

(a) N Engl J Med 1996;335:1107-1114
(b) Cardiology 1998;89 Suppl 1:38-46

PRAISE -II
Prospective Randomized AmlodIpine Survival Evaluation - II
Eur J Heart Fail 2000 Jun;2(2):209-12(Clinical trials update)

PRCCT
Prospective Randomized Controlled Clinical Trials

PRECISE
Prospective Randomized Evaluation of Carvedilol In Symptoms and Exercise
Circulation 1996 Dec 1;94(11):2793-9

PREDICT
Prevention des Restenoses par Elisor, apres Dilatation Coronaire Transluminale
J Am Coll Cardiol 1997 Oct;30(4):863-9

PREDICT
Prospective Randomized Evaluation of Diltiazem CD Trial

PREMIS
PREhospital Myocardial Infarction Study
Lancet 1984;ii:883-6

PREPIC
Prevention du Risque Embolique Pulmonaire par Interruption Cave

PRESANCE
Prevention de la REStenose apres ANgioplastie Coronaire Elective

PRESERVE
Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement
Am J Cardiol 1996 Jul 1;78(1):61-5

PRESERVE (Substudy)
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy
Am J Cardiol 1999 Sep 1;84(5):558-62

PRESTO
Prevention of REStenosis with Tranilast and its Outcomes
Am Heart J 2000 Jan;139(1 Pt 1):23-31

PREVENT
Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial

(a) Circulation 2000 Sep 26;102(13):1503-10
(b) Can J Cardiol 2000 Jul;16 Suppl D:5D-7D
(c) Clin Cardiol 1999;22:47-49
(d) Circulation 1999;99:2486-2491

PRHHP
Puerto Rico Heart Health Program

PRIME
Promotion of Reperfusion In Myocardial-infarction Evolution

PRIME
Prospective Randomized Ibopamine Mortality Evaluation

PRIME II
second Prospective Randomized study of Ibopamine on Mortality and Efficacy

(a) Eur J Heart Fail 1999 Mar;1(1):89-93
(b) Lancet 1997;349:971-977
(c) Lancet 1997 Jul 12;350(9071):147-8
(d) Eur Heart J 1997 Oct;18(10):1519-20

PRIMI
PRo-urokinase in Myocardial Infarction trial
(a) Lancet 1989;i:863-868
(b) Eur Heart J 1992;13:1225-1232

PRINCE
Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation
J Am Coll Cardiol 1999;33:403-411

PRISM
Platelet Receptor inhibition for Ischemic Syndrome Management study
N Engl J Med 1998;378:1498-1505

PRISM-PLUS
Platelet Receptor inhibition for Ischemic Syndrome Management in Patients Limited to very Unstable Signs and Symptoms trial
(a) Circulation 2000 Nov 14;102(20):2466-72
(b) Circulation 1999 Oct 12;100(15):1609-15
(c) N Engl J Med 1998;338:1488-1497
(d) N Engl J Med 1998 May 21;338(21):1498-505

PRIST
Prognosis in patients with Recent Ischemic Stroke by Transesophageal echocardiography

PRISTINE
PRaxilene In Stroke Treatment In Northern Europe

PROCAT II
Prolyse in acute Cerebral Thromboembolism II
JAMA 1999 Dec 1;282(21):2003-11

PROACT
PROurokinase for Acute Cerebral Thromboembolism

PROACT
PROurokinase in ACute Thromboembolic stroke
Stroke 1998 Jan;29(1):4-11

PROCAM
PROspective CArdiovascular Munster study
(a) Am J cardiol 1987;59:9G-17G
(b) Am Heart J 1988;116:1713-1724
(c) Am J Cardiol 1992;70:733-737

PROFILE
Prospective RandOmized Flosequlnan Longevity Evaluation
Because of the high mortality the PROFILE study was stopped. (see the FACET trial and REFLECT trial)

PROLOG
PRecursor tO EPILOG study

PROLOGUS
PROgetto LOngftudinale GUSago

PROMISE
Prospective RandOmized MIlrinone Survival Evaluation
(a) Am J Cardiol 1989;63(suppl A):41-45A
(b)N Engl J Med 1991 Nov 21;325(21):1468-75

PROMISE (Substudy)
Prospective RandOmized MIlrinone Survival Evaluation
J Am Coll Cardiol 1993 Mar 1;21(3):634-40

PROTECT
Perindopril Regression Of vascular Thickness European Community Trial
(a) J Hypertens 1993;11(suppl 5):S316-S317
(b) Am J Cardiol 1995;76:50E-54E

PROTECT
Prospective Reinfarction Outcomes in Thrombolytic Era Cardizem CD Trial

PROVED
Prospective Randomized study Of Ventricular failure and the Efficacy of Digoxin
J Am Coll Cardiol 1993;22:955-962

PSC
Prospective Studies Collaboration

PSG
Paris-Saint-Germain

PTP
Petach Tikva Project:Comparison of coronary risk factors in Israeli children of different ethnic groups
Prevalence of cardiovascular risk factors in children
Am J Epidemiol 1993 Mar 1;137(5):549-58

PURSUIT
Platelet IIb/IIIa Underpinning the Receptor for Suppression of Unstable Ischemia Trial
Circulation 1996;94:2083-2089

PURSUIT (Substudies)
Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
(a) Circulation 2000;101:751-757
(b) N Engl J Med 1998;339:436-443
(c) Am J Cardiol 1997;80(4A):34B-38B

PUTS
Perindopril Therapeutic Safety study
Am J Cardiol 1993;71:32E-37E

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /

e-mail:shindler@umdnj.edu
Copyright © 1995-2001 Dr. Olga Shindler.